$KLTR
KALTURA INC Stock $kltr

$kltr Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000117891321002793 Filed on August 19, 2021

Income Statement

Concept	2021 Q3	2021 Q2
Revenue	$42.98M	$41.60M
YoY Change	40.43%	44.71%
Cost Of Revenue	$15.17M	$15.62M
YoY Change	21.2%	44.81%
Gross Profit	$27.82M	$25.98M
YoY Change	53.74%	44.65%
Gross Profit Margin	64.71%	62.45%
Selling, General & Admin	$21.33M	$19.96M
YoY Change	40.03%	92.91%
% of Gross Profit	76.67%	76.84%
Research & Development	$12.36M	$11.79M
YoY Change	69.94%	81.65%
% of Gross Profit	44.44%	45.37%
Depreciation & Amortization	$375.0K	$332.0K
YoY Change	-54.82%	-60.24%
% of Gross Profit	1.35%	1.28%
Operating Expenses	$33.69M	$31.75M
YoY Change	49.7%	88.57%
Operating Profit	-$5.873M	-$5.770M
YoY Change	33.14%	-613.8%
Interest Expense	$766.0K	$611.0K
YoY Change	-26.13%	-40.04%
% of Operating Profit
Other Income/Expense, Net	-$17.78M	$4.497M
YoY Change	1065.9%	-138.85%
Pretax Income	-$23.65M	-$1.273M
YoY Change	298.47%	-87.82%
Income Tax	$1.497M	$1.446M
% Of Pretax Income
Net Earnings	-$25.15M	-$2.719M
YoY Change	290.89%	-75.3%
Net Earnings / Revenue	-58.51%	-6.54%
Basic Earnings Per Share	-$0.26	$0.24
Diluted Earnings Per Share	-$244.3K	$0.37
COMMON SHARES
Basic Shares Outstanding	126.5M shares	25.77M shares
Diluted Shares Outstanding	102.9M shares	32.84M shares

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$179.7M	$29.77M
YoY Change
Cash & Equivalents	$179.7M	$29.77M	$27.71M
Short-Term Investments
Other Short-Term Assets	$172.0K	$12.26M	$56.00K
YoY Change
Inventory
Prepaid Expenses	$7.007M		$2.086M
Receivables	$24.19M	$23.75M	$17.13M
Other Receivables	$170.0K	$0.00	$335.0K
Total Short-Term Assets	$220.5M	$65.78M	$53.46M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.243M	$7.259M	$4.147M
YoY Change
Goodwill		$11.07M	$11.07M
YoY Change			18.0%
Intangibles		$2.347M	$2.835M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.371M	$4.949M	$3.564M
YoY Change
Total Long-Term Assets	$47.01M	$46.35M	$37.49M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$220.5M	$65.78M	$53.46M
Total Long-Term Assets	$47.01M	$46.35M	$37.49M
Total Assets	$267.5M	$112.1M	$90.95M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.418M	$5.196M	$5.045M
YoY Change
Accrued Expenses	$7.464K	$34.88M	$4.687M
YoY Change
Deferred Revenue		$59.07M	$47.69M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.820M	$1.743M	$1.000M
YoY Change
Total Short-Term Liabilities	$108.0M	$101.8M	$82.99M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$58.99M	$59.75M	$47.16M
YoY Change
Other Long-Term Liabilities	$4.136M	$2.331M	$2.706M
YoY Change
Total Long-Term Liabilities	$63.13M	$117.7M	$108.5M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$108.0M	$101.8M	$82.99M
Total Long-Term Liabilities	$63.13M	$117.7M	$108.5M
Total Liabilities	$171.1M	$219.5M	$191.5M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings		-$281.6M	-$263.3M
YoY Change
Common Stock		$17.84M	$8.390M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$4.881M	$4.881M
YoY Change
Treasury Stock Shares		7.685M shares	7.685M shares
Shareholders Equity	$96.34M	-$268.6M	-$260.7M
YoY Change
Total Liabilities & Shareholders Equity	$267.5M	$112.1M	$90.95M
YoY Change

Cashflow Statement

Concept	2021 Q3	2021 Q2
OPERATING ACTIVITIES
Net Income	-$25.15M	-$2.719M
YoY Change	290.89%	-75.3%
Depreciation, Depletion And Amortization	$375.0K	$332.0K
YoY Change	-54.82%	-60.24%
Cash From Operating Activities	-$5.675M	$869.0K
YoY Change		-69.25%
INVESTING ACTIVITIES
Capital Expenditures	-$2.122M	-$1.033M
YoY Change		46.11%
Acquisitions
YoY Change
Other Investing Activities	$642.0K	$0.00
YoY Change
Cash From Investing Activities	-$1.480M	-$1.033M
YoY Change		46.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	157.1M	10.93M
YoY Change		-1831.54%
NET CHANGE
Cash From Operating Activities	-5.675M	869.0K
Cash From Investing Activities	-1.480M	-1.033M
Cash From Financing Activities	157.1M	10.93M
Net Change In Cash	150.0M	10.76M
YoY Change		623.25%
FREE CASH FLOW
Cash From Operating Activities	-$5.675M	$869.0K
Capital Expenditures	-$2.122M	-$1.033M
Free Cash Flow	-$3.553M	$1.902M
YoY Change		-46.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2021Q2	kltr	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	5928000	USD
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7259000	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27711000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17134000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	65782000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	53462000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4147000	USD
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126489472	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29772000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4714000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41603000	USD
CY2021Q2	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1	pure
CY2020Q2	kltr	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	0	USD
	kltr	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	0	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2021Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	894000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5045000	USD
CY2021Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	14521000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59070000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	101784000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23747000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3564000	USD
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2835000	USD
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	46354000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	2769000	USD
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	59749000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	47160000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2331000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2564000	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	53855000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	56780000	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	117690000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	108504000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	219474000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	191498000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	160112000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	157500000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	157500000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33153112	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25467922	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7685190	shares
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	7685190	shares
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	4881000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5196000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	20360000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	7549000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	5848000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4949000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	20729000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	15876000	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2347000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	11070000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	11070000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	37492000	USD
CY2021Q2	us-gaap	Assets Assets	112136000	USD
CY2020Q4	us-gaap	Assets Assets	90954000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1743000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1000000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1738000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16275000	USD
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	11251000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	47685000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	82994000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1752000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1858000	USD
CY2021Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	3000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	142000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	161261000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33479452	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25794262	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2020Q4	kltr	Treasury Shares Par Value Per Share TreasurySharesParValuePerShare	0.0001
CY2021Q2	kltr	Treasury Shares Par Value Per Share TreasurySharesParValuePerShare	0.0001
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4881000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41603000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28749000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	79316000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54655000	USD
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	15622000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	10788000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	31203000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	21204000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	25981000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	17961000	USD
	us-gaap	Gross Profit GrossProfit	48113000	USD
	kltr	Non Cash Interest Expenses NonCashInterestExpenses	222000	USD
	kltr	Non Cash Interest Expenses NonCashInterestExpenses	43000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	17838000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3828000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8388000	USD
CY2021Q2	kltr	Receivables On Account Of Stock ReceivablesOnAccountOfStock	0	USD
CY2020Q4	kltr	Receivables On Account Of Stock ReceivablesOnAccountOfStock	882000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-281558000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-263283000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-268599000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-260656000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112136000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90954000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17387000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8183000	USD
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
	kltr	Non Cash Expenses With Respect To Stockholders Loans NonCashExpensesWithRespectToStockholdersLoans	882000	USD
	us-gaap	Gross Profit GrossProfit	33451000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11787000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6489000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22687000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13268000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10524000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6521000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20685000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14800000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9440000	USD
CY2021Q2	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2020Q2	us-gaap	Other General Expense OtherGeneralExpense	0	USD
	us-gaap	Other General Expense OtherGeneralExpense	1724000	USD
	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	31751000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	16838000	USD
	us-gaap	Operating Expenses OperatingExpenses	62483000	USD
	us-gaap	Operating Expenses OperatingExpenses	36251000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5770000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1123000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14370000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2800000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4497000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11575000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-653000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11284000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1273000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10452000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15023000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14084000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1446000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	554000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3252000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1906000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2719000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-11006000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18275000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15990000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25768411	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25174126	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25538010	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24575196	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32836110	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25174126	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25538010	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24575196	shares
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9173000	USD
	kltr	Loan Forgiveness LoanForgiveness	882000	USD
	kltr	Issuance Of Preferred Stock Value Upon Exercise Of Warrants IssuanceOfPreferredStockValueUponExerciseOfWarrants	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18275000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15990000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-224512000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18275000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15990000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2093000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9173000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1796000	USD
	kltr	Increase In Deferred Contract Acquisition And Fulfillment Costs IncreaseInDeferredContractAcquisitionAndFulfillmentCosts	6554000	USD
	kltr	Increase In Deferred Contract Acquisition And Fulfillment Costs IncreaseInDeferredContractAcquisitionAndFulfillmentCosts	1769000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1776000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	10034000	USD
	kltr	Non Cash Expenses With Respect To Stockholders Loans NonCashExpensesWithRespectToStockholdersLoans	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6612000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	692000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1945000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	215000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-177000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-415000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3112000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2801000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4085000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	989000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-309000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	219000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11279000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2082000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5695000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3188000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	383000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	956000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	566000	USD
	us-gaap	Payments For Software PaymentsForSoftware	1255000	USD
	us-gaap	Payments For Software PaymentsForSoftware	382000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	79000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	89000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2290000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-654000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	41915000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2000000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	28833000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	956000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1267000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	277000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	26000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2594000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9809000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	759000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1824000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3083000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28355000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27144000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30179000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24061000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1534000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	75000	USD
	kltr	Issuance Of Ordinary Shares And Warrant With Respect To Business Combination IssuanceOfOrdinarySharesAndWarrantWithRespectToBusinessCombination	0	USD
	kltr	Issuance Of Ordinary Shares And Warrant With Respect To Business Combination IssuanceOfOrdinarySharesAndWarrantWithRespectToBusinessCombination	3799000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	946000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	543000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1215000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1939000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29772000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23456000	USD
CY2021Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	407000	USD
CY2020Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	605000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30179000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24061000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.65	pure
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28749000	USD
CY2020Q2	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1	pure
	us-gaap	Use Of Estimates UseOfEstimates	<div> <div> <div style="line-height:1.25"> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:28.35pt;vertical-align:top;align:right"> </td> <td style="width:auto;vertical-align:top;text-align:justify"> <div> <div style="line-height:1.25"><em><strong>Use of Estimates</strong></em></div> <div style="line-height:1.25"> </div> <div style="line-height:1.25">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, income tax uncertainties, stock-based compensation cost, fair value measurement of warrants, accretion of redeemable stocks, fair value and useful life of intangible assets, as well as in estimates used in applying the revenue recognition policy. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</div> <div style="line-height:1.25"> </div> <div style="line-height:1.25"> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">Due to the Coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require a material update to its estimates or judgments or an adjustment of the carrying value of its assets or liabilities as of June 30, 2021. While there was not a material impact to the Company’s condensed consolidated financial statements as of and for the three and six months ended June 30, 2021, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 and its variants that could result in material impacts to the Company’s condensed consolidated financial statements in future reporting periods.</div> </div> <div style="line-height:1.25"> </div> <div style="line-height:1.25;font-style:italic;font-weight:bold">Restatement of previously consolidated financial statements</div> <div style="line-height:1.25"> </div> <div style="line-height:1.25"> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">The Company has restated its previously issued consolidated financial statements as of the year ended December 31, 2020, to amend the underlying assumptions used in its common stock valuation work. See Note 20 to the consolidated financial statements included in the Company’s Prospectus for further information.</div> </div> </div> </td> </tr> </table> </div> </div> </div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic;font-weight:bold"> </div> <div> <div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:28.35pt;vertical-align:top;align:right"> </td> <td style="width:auto;vertical-align:top;text-align:justify"> <div> <div style="line-height:1.25;font-style:italic;font-weight:bold">Concentration of Risks</div> <div style="line-height:1.25"> </div> <div style="line-height:1.25">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash and trade receivables.</div> <div style="line-height:1.25"> </div> <div style="line-height:1.25">The majority of the Company’s and its subsidiaries’ cash, and cash equivalents and restricted cash are invested with major banks in the United States, Israel, and the United Kingdom. Such investments in the United States may be in excess of insured limits and they are not insured in other jurisdictions. In general, these investments may be redeemed upon demand and therefore bear minimal risk.</div> <div style="line-height:1.25"> </div> <div style="line-height:1.25">The Company’s trade receivables are geographically dispersed and derived from sales to customers mainly in the United States, Europe, and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation, and account monitoring procedures.</div> <div style="line-height:1.25"> </div> <div style="line-height:1.25">Major customer data as a percentage of total revenues:</div> <div style="line-height:1.25"> </div> <div style="line-height:1.25">The following table sets forth a customer that represented 10% or more of the Company’s total revenue in each of the periods set forth below:</div> </div> </td> </tr> </table> </div> </div> <div style="line-height:1.25"> </div> <div> <div> <div> <div> <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;margin-left:118px;margin-right:0px;width:83%"> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold">Three months ended June 30,</div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold">Six months ended June 30,</div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold">2021</div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold">2020</div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold">2021</div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold">2020</div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="14" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold">(unaudited)</div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25">Customer A (M&T) </div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="-sec-ix-hidden:Fxbrl_20210817205210112"></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25">12.03</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="-sec-ix-hidden:Fxbrl_20210817205232794"></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25">12.90</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> </tr> <tr> <td style="vertical-align:bottom;width:52%;padding-bottom:4px" valign="bottom"> <div style="line-height:1.25">Customer B (EE&T)</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25"><span style="-sec-ix-hidden:Fxbrl_20210817205353082"></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25"><span style="-sec-ix-hidden:Fxbrl_20210817205357830"></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25">$</div> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25">10.01</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25"><span style="-sec-ix-hidden:Fxbrl_20210817205402122"></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"> <div style="line-height:1.25">%</div> </td> </tr> </table> </div> </div> </div> </div> <div style="line-height:1.25;clear:both"> </div> <div style="text-align:justify;text-indent:-28.35pt;margin-left:110pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> ) Represents an amount that is lower than 10% of the Company’s total revenue.</span></span></div> </div>
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5752000	USD
CY2021Q2	kltr	Revenue Remaining Performance Obligation Billed Consideration Amount RevenueRemainingPerformanceObligationBilledConsiderationAmount	60822000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32836110	shares
CY2021Q2	kltr	Revenue Remaining Performance Obligation Unbilled Consideration Amount RevenueRemainingPerformanceObligationUnbilledConsiderationAmount	95501000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	79316000	USD
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54655000	USD
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1	pure
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	156323000	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	53855000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	271000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	554000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	256000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	567000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3252000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1906000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	406000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25174126	shares
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	1.14	pure
CY2020Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.05	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.22	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.14	pure
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25538010	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24575196	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	438000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	666000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	554000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	478000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	148000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	63000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1446000	USD
CY2021Q2	us-gaap	Depreciation Depreciation	332000	USD
CY2020Q2	us-gaap	Depreciation Depreciation	835000	USD
	us-gaap	Depreciation Depreciation	633000	USD
	us-gaap	Depreciation Depreciation	1687000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2021Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	3412000	USD
CY2020Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2968000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	6672000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	5609000	USD
	kltr	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	0	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12059000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13974000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24947000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-21599000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25768411	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25174126	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25538010	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24575196	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	7067699	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	16850111	shares
	kltr	Incremental Common Shares Attributable To Dilutive Effect For Warrants To Purchase Preferred And Common Stock IncrementalCommonSharesAttributableToDilutiveEffectForWarrantsToPurchasePreferredAndCommonStock	7680954	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	31488683	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	56019748	shares
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	500000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	52500000	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	62000000	USD
CY2021Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	17012609	shares
CY2021Q2	kltr	Temporary Equity Shares Issued And Outstanding TemporaryEquitySharesIssuedAndOutstanding	16850111	shares
CY2021Q2	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	194122000	USD
CY2021Q1	kltr	Number Of Warrants Converted NumberOfWarrantsConverted	31414	shares
CY2021Q1	kltr	Number Of Preferred Shares Issued In Conversion Of Warrants NumberOfPreferredSharesIssuedInConversionOfWarrants	27011	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	45482679	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	18106866	shares
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-653000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
	kltr	Financial Expenses FinancialExpenses	12278000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11284000	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4213000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1134000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9173000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1796000	USD
	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4.5	pure
CY2021Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	0	USD
CY2020Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	0	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	0	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	17000	USD
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5928000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1776000	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	191000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	977000	USD
CY2021Q2	kltr	Financial Income FinancialIncome	5928000	USD
CY2020Q2	kltr	Financial Income FinancialIncome	191000	USD
	kltr	Financial Income FinancialIncome	1776000	USD
	kltr	Financial Income FinancialIncome	994000	USD
CY2021Q2	kltr	Bank Fees BankFees	172000	USD
CY2020Q2	kltr	Bank Fees BankFees	19000	USD
	kltr	Bank Fees BankFees	481000	USD
	kltr	Bank Fees BankFees	34000	USD
CY2020Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	10625000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	10034000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	611000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	1019000	USD
	us-gaap	Interest Expense InterestExpense	1462000	USD
	us-gaap	Interest Expense InterestExpense	2027000	USD
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-499000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-274000	USD
CY2021Q2	us-gaap	Interest Expense Other InterestExpenseOther	149000	USD
CY2020Q2	us-gaap	Interest Expense Other InterestExpenseOther	103000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	212000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	183000	USD
CY2021Q2	kltr	Financial Expenses FinancialExpenses	1431000	USD
CY2020Q2	kltr	Financial Expenses FinancialExpenses	11766000	USD
	kltr	Financial Expenses FinancialExpenses	2429000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4497000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11575000	USD

Files In Submission

Name	View Source	Status
0001178913-21-002793-index-headers.html	Edgar Link	pending
0001178913-21-002793-index.html	Edgar Link	pending
0001178913-21-002793.txt	Edgar Link	pending
0001178913-21-002793-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kltr-20210630.xsd	Edgar Link	pending
kltr-20210630_cal.xml	Edgar Link	unprocessable
kltr-20210630_def.xml	Edgar Link	unprocessable
kltr-20210630_lab.xml	Edgar Link	unprocessable
kltr-20210630_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk2126376.htm	Edgar Link	pending
zk2126376_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KLTR
KALTURA INC Stock $kltr

2021 Q3 Form 10-Q Financial Statement

#000117891321002793 Filed on August 19, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLTR KALTURA INC Stock $kltr

2021 Q3 Form 10-Q Financial Statement

#000117891321002793 Filed on August 19, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLTR
KALTURA INC Stock $kltr